Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. May 28, 2007; 13(20): 2852-2854
Published online May 28, 2007. doi: 10.3748/wjg.v13.i20.2852
Published online May 28, 2007. doi: 10.3748/wjg.v13.i20.2852
Table 1 Patient characteristics
| Characteristics | No. of patients (n = 42) |
| Age (yr) | |
| Median | 51 |
| (range) | (33-67) |
| Sex | |
| Female | 14 (33%) |
| Male | 28 (67%) |
| ECOG performance status | |
| 0-1 | 35 (83%) |
| 2 | 7 (17%) |
| Disease | |
| Unresectable | 12 (28%) |
| Metastatic disease | 30 (72%) |
- Citation: Charoentum C, Thongprasert S, Chewaskulyong B, Munprakan S. Experience with gemcitabine and cisplatin in the therapy of inoperable and metastatic cholangiocarcinoma. World J Gastroenterol 2007; 13(20): 2852-2854
- URL: https://www.wjgnet.com/1007-9327/full/v13/i20/2852.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i20.2852